Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval
- PMID: 18031366
- DOI: 10.1111/j.1440-1746.2006.04362.x
Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval
Abstract
Background and aims: Unlike most other countries, in China, liver failure is termed as severe hepatitis. However, there are two differences between liver failure and severe hepatitis: the interval of acute and sub-acute severe hepatitis and the etiology. The aims of this study were to assess the best cutoff time-point to distinguish between acute and sub-acute severe hepatitis caused mainly by hepatitis B virus (HBV; 67.5%) in China and to determine whether the Chinese classifications of severe hepatitis can meet the international criteria based on pathological features and clinical characteristics.
Methods: A total of 157 patients with acute, sub-acute and chronic severe hepatitis were involved in the study. Their clinical findings, laboratory data and liver biopsies were retrospectively analyzed.
Results: The different incidences of complications between acute and sub-acute severe hepatitis were significant if the cutoff point was set at 15 days or 4 weeks (P < 0.01), but there is no significant differences if the cutoff was 8 weeks. Identifying the better cutoff point with a receiver-operator characteristic curve showed that 28 days was better than 15 days (sensitivity 100%vs 92%; specificity 75%vs 53%). The major differences in histopathology between acute and sub-acute severe hepatitis were: (i) there was a single hepatic necrosis in acute severe hepatitis, but repeated and continuous hepatic necrosis in sub-acute severe hepatitis; and (ii) survivors of acute severe hepatitis had full hepatocyte regeneration in the native liver architecture. Regeneration in survivors with sub-acute severe hepatitis indicated the destruction of nodular architecture; new and old necrosis appeared at the same time. When the cutoff point for acute and sub-acute severe hepatitis was set at 15 days, some sub-acute severe hepatitis cases (full hepatocyte regeneration and one massive necrosis) had an overlap in pathological features with acute severe hepatitis. If the cutoff time-point was set at 4 weeks, the clinical features between acute and sub-acute, as well as the pathological changes, were clearly distinguished.
Conclusion: The best cutoff time-point to distinguish between acute and sub-acute severe hepatitis is 4 weeks. This classification meets the international criteria based on the present clinical and pathological results.
Similar articles
-
[A retrospective study of clinical and pathological spectrum in 91 patients with chronic severe hepatitis B].Zhonghua Gan Zang Bing Za Zhi. 2010 Oct;18(10):721-5. doi: 10.3760/cma.j.issn.1007-3418.2010.10.001. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21059285 Chinese.
-
Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.Liver Int. 2009 Mar;29(3):392-8. doi: 10.1111/j.1478-3231.2008.01887.x. Liver Int. 2009. PMID: 19267864
-
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure.Clin Gastroenterol Hepatol. 2008 Mar;6(3):339-45. doi: 10.1016/j.cgh.2007.12.039. Clin Gastroenterol Hepatol. 2008. PMID: 18328438
-
Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.J Gastroenterol Hepatol. 2009 Jul;24(7):1179-86. doi: 10.1111/j.1440-1746.2009.05924.x. J Gastroenterol Hepatol. 2009. PMID: 19682192 Review.
-
Etiology and prognosis of fulminant hepatitis in adults.Liver Transpl. 2008 Oct;14 Suppl 2:S67-79. doi: 10.1002/lt.21612. Liver Transpl. 2008. PMID: 18825677 Review.
Cited by
-
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.J Viral Hepat. 2010 Dec;17(12):887-95. doi: 10.1111/j.1365-2893.2009.01254.x. J Viral Hepat. 2010. PMID: 20070500 Free PMC article.
-
Invasive pulmonary aspergillosis in patients with HBV-related liver failure.Eur J Clin Microbiol Infect Dis. 2011 May;30(5):661-7. doi: 10.1007/s10096-010-1137-2. Epub 2011 Jan 4. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21197619
-
Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure.BMC Gastroenterol. 2020 Mar 13;20(1):75. doi: 10.1186/s12876-020-01191-5. BMC Gastroenterol. 2020. PMID: 32188419 Free PMC article.
-
Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B.Hepatol Int. 2013 Jun;7(2):460-7. doi: 10.1007/s12072-012-9415-y. Epub 2013 Feb 11. Hepatol Int. 2013. PMID: 26201778
-
Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population.BMC Med Genet. 2012 Jun 24;13:49. doi: 10.1186/1471-2350-13-49. BMC Med Genet. 2012. PMID: 22727021 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources